United Therapeutics Corp
F:UTH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
U
|
United Therapeutics Corp
F:UTH
|
US |
|
D
|
Dexcom Inc
XMUN:DC4
|
US |
|
E
|
Eastman Chemical Co
XMUN:EAC
|
US |
|
Siloam International Hospitals Tbk PT
F:2LS
|
ID |
|
B
|
Blue Label Telecoms Ltd
XMUN:5TP
|
ZA |
|
N
|
Norwegian Cruise Line Holdings Ltd
F:1NC
|
US |
|
A
|
Aurinia Pharmaceuticals Inc
F:IKAP
|
CA |
Intrinsic Value
The intrinsic value for
United Therapeutics Corp (UTH) under the Base Case is hidden
EUR.
Compared with the current market price of 457.4 EUR, the stock appears hidden
.
UTH looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether UTH usually does or if today's premium is unusual.
Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for United Therapeutics Corp.
Fundamental Analysis
Revenue & Expenses Breakdown
United Therapeutics Corp
Earnings Waterfall
United Therapeutics Corp
The intrinsic value for
United Therapeutics Corp (UTH) under the Base Case is hidden EUR.
Compared with the current market price of 457.4 EUR, the stock appears hidden.